239 related articles for article (PubMed ID: 28860148)
21. A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Wojtowicz A; Selman SH; Jankun J
Mol Cancer Ther; 2003 Jan; 2(1):19-28. PubMed ID: 12533669
[TBL] [Abstract][Full Text] [Related]
22. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
23. Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.
Tucker TA; Idell S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163509
[TBL] [Abstract][Full Text] [Related]
24. Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion.
Abdul Hamid MF; Hasbullah AHH; Mohamad Jailaini MF; Nik Abeed NN; Ng BH; Haron H; Md Ali NA; Ismail MI; Nik Ismail NA; Abdul Rahman MR; Ban AY
BMC Pulm Med; 2022 Nov; 22(1):439. PubMed ID: 36419155
[TBL] [Abstract][Full Text] [Related]
25. A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of plasminogen activator inhibitor type-1.
D'Amico S; Martial JA; Struman I
FEBS Lett; 2012 Mar; 586(6):686-92. PubMed ID: 22449964
[TBL] [Abstract][Full Text] [Related]
26. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
27. Gene expression of fibrinolytic factors urokinase plasminogen activator and plasminogen activator inhibitor-1 in rabbit temporo-mandibular joint cartilage with disc displacement.
Zhan J; Gu ZY; Wu LQ; Zhang YK; Hu JA
Chin Med J (Engl); 2005 Jun; 118(12):1000-6. PubMed ID: 15978208
[TBL] [Abstract][Full Text] [Related]
28. The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
Br J Pharmacol; 2000 Oct; 131(4):858-64. PubMed ID: 11030738
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
30. Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding.
Verhamme I; Kvassman JO; Day D; Debrock S; Vleugels N; Declerck PJ; Shore JD
J Biol Chem; 1999 Jun; 274(25):17511-7. PubMed ID: 10364183
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.
Huber K
J Thromb Thrombolysis; 2001 May; 11(3):195-202. PubMed ID: 11577257
[TBL] [Abstract][Full Text] [Related]
32. The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot AJ; van Tienoven DT; Beex LV; Sweep FC
Thromb Haemost; 2004 Mar; 91(3):514-21. PubMed ID: 14983227
[TBL] [Abstract][Full Text] [Related]
33. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
[TBL] [Abstract][Full Text] [Related]
34. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.
Idell S; Mazar A; Cines D; Kuo A; Parry G; Gawlak S; Juarez J; Koenig K; Azghani A; Hadden W; McLarty J; Miller E
Am J Respir Crit Care Med; 2002 Oct; 166(7):920-6. PubMed ID: 12359647
[TBL] [Abstract][Full Text] [Related]
35. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.
Feng Y; Zhang F; Niu L; Zhang M
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):531-41. PubMed ID: 27273142
[TBL] [Abstract][Full Text] [Related]
37. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
38. Localization of epitopes for monoclonal antibodies to urokinase-type plasminogen activator: relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme.
Petersen HH; Hansen M; Schousboe SL; Andreasen PA
Eur J Biochem; 2001 Aug; 268(16):4430-9. PubMed ID: 11502203
[TBL] [Abstract][Full Text] [Related]
39. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
40. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S
Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
